James Bay Minerals (ASX:JBY) Commences Drilling at Independence Project
James Bay Minerals (ASX:JBY) begins a 4,000m drill program at Independence Project’s Rebel Trend, targeting significant gold resource growth.
Tag: Industry-Specific News
Desert Metals Limited (ASX:DM1) Commences Drilling Programs and Secures Placement
Desert Metals (ASX:DM1) initiates comprehensive drilling programs in Côte d’Ivoire and secures AUD 3.25m funding through placement.
Resolution Minerals (ASX:RML) Acquires High-Grade Antimony-Gold Portfolio
Resolution Minerals (ASX:RML) acquires high-grade antimony and gold projects in NSW and QLD, enhancing its strategic mining portfolio.
BMG Resources (ASX:BMG) Accelerates Gold Exploration in Western Australia
BMG Resources (ASX:BMG) accelerates gold exploration at Bullabulling and Invincible Projects, leveraging high-grade discoveries and strategic acquisitions.
Prescient Therapeutics (ASX:PTX) Initiates Phase 2a PTX-100 Clinical Study
Prescient Therapeutics (ASX:PTX) initiates Phase 2a clinical study for PTX-100, marking a significant milestone in treating Cutaneous T-Cell Lymphoma.
AXP Energy Limited (ASX:AXP) Advances Second Gas-to-Power-Bitcoin Site
AXP Energy Limited (ASX:AXP) announces the scale-up of its second gas-to-power-bitcoin site, aiming for 25 MW/hr generation by CY2025.
Patriot Battery Metals Inc. (ASX:PMT) Discovers New Spodumene Pegmatite Cluster
Patriot Battery Metals Inc. (ASX:PMT) discovers the CV15 spodumene pegmatite cluster, significantly expanding the Mickel Trend at its Shaakichiuwaanaan Property.
Wildcat Resources Limited (ASX:WC8) Announces Strong Drilling Results for Lithium and Gold Projects
Wildcat Resources (ASX:WC8) reports robust drilling results at its Tabba Tabba Lithium and Mt Adrah Gold projects, underpinned by a strong financial position.
LTR Pharma Limited (ASX:LTP) Advances Multi-Market Strategy with FDA Milestone and Roxus Launch
LTR Pharma (ASX:LTP) achieves FDA approval path for SPONTAN and launches Roxus to accelerate US market entry.
Clinuvel (ASX:CUV) Announces Positive Preliminary Stroke Study Results
CLINUVEL (ASX:CUV) reports positive preliminary results from its latest stroke treatment study, highlighting high patient improvement rates.